poisar

Stocks · News reference

Kura Oncology and Kyowa Kirin Announce Acceptance of Eight Abstracts for 2026 ASH Annual Meeting

Fiscal.ai

Kura Oncology and Kyowa Kirin announced that eight abstracts regarding ziftomenib have been accepted for presentation at the 2026 American Society of Hematology (ASH) Annual Meeting.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading